Pseudohypertrophic myopathy

Pseudohypertrophic myopia (or Duchenne muscular dystrophy, or DUCHENNE-BALERDINO SYNDROME) is a hereditary neuromuscular disease with a gradual onset and leading impairment of voluntary muscle movements. The disease is associated with changes in the dystrophin gene, which encodes the main structural protein of muscle tissue. Myopathy begins to manifest itself in early childhood, first affecting the muscles of the trunk, then the arms, and subsequently the legs.

A characteristic manifestation of Duchenne disease is wasting of the leg muscles, especially in the calf area. Myopetic pseudohypertophy (or flaccid) manifests itself more visually: initially, the disease manifests itself as fatigue and excessive difficulty when walking. The rate of development of the disease is quite slow, the patient begins to walk slowly and unsteadily, and characteristic difficulties appear when climbing stairs. Then

Pseudohypertropic myopathy is an inherited disease that leads to various forms of muscle weakness, decreased motor coordination, and the inability to stand up and walk without assistance in patients of this type.

Myopathy is an incurable genetic disease characterized by muscle weakness, weak muscle tension, increased fatigue during physical activity, and gait disturbance. This is due to the production of the dystrophin protein in the human body. The absence of dystrophin increases the risk of myopathies, which lead to muscle necrosis.

Myopathies are rare inherited disorders associated with deficiencies or changes in certain muscle proteins. Myopathies can be caused by gene mutations or disorders of the gene encoding one of these proteins. There are several types of myopathies.

One of the common myopathies is Duchenne myopathy. It develops from